N/A N=148

PRescriptiOn PattERns Of Oral Anticoagulants

Atrial Fibrillation

Bottom Line

View on ClinicalTrials.gov: NCT02366338 ↗

Enrolled (actual)

148

Serious AEs

0.0%

Results posted

May 2015

Primary outcome: Primary: Number of Patients With at Least One Inappropriate MAI Criterion — 61; 11; 17 participants

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: —
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Muğla Sıtkı Koçman University
Primary completion: Nov 2014

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Patients With at Least One Inappropriate MAI Criterion	61; 11; 17	—

Summary

Atrial fibrillation is the major cause of acute ischemic stroke. The risk of stroke was shown to decline by oral anticoagulant therapy. The investigators intended to evaluate appropriate use of anticoagulants in non-valvular AF patients.

Eligibility Criteria

Inclusion Criteria

Non valbular AF >18 years

Exclusion Criteria

Not currently receiving anticoagulant

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02366338). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.